Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC

Luis E. Raez, MD, FACP

Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC

Luis E. Raez, MD, FACP